Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1981-08-10
1983-12-27
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, A61K 3910
Patent
active
044230354
ABSTRACT:
A method of vaccinating a food producing animal without producing injection site abscess comprising injecting said animal with a vaccine that comprises a bacterin, an effective amount of a compatible adjuvant, an effective amount of a non-antibiotic biocidal compound, and about 30 micrograms per milliliter of gentamicin sulfate.
REFERENCES:
patent: 3091572 (1962-07-01), Luedeman et al.
patent: 3419660 (1968-12-01), Lannon
patent: 4225583 (1980-09-01), Switzer et al.
patent: 4250265 (1981-02-01), Carlo et al.
Oden et al., Dev. Biol., 24, 181-187 (1974).
Abstract of the Leptospira bacterin manufactured by Affiliated Labs (Veterinary Pharmaceuticals & Biologicals 76/77).
Abstract of the Pasteurella bacterin manufactured by Affiliated Labs (Veterinary Pharmaceuticals & Biologicals 76/77).
Edison et al., Poultry Science 57, 1519-25 (1978).
Wallack, Nouv. Presse Med. 8, No. 23, 1919-1921 (1979), (with translation).
Koinis et al., Schweiz Rundschau Med. (Praxis) 64, 1176-1179 (1975) (with translation).
Chemical Abstracts, vol. 93, p. 8, Abst. No. 88385h, 1980.
Eisen Bruce M.
Gifford Vincent H.
Hazel Blondel
Lee, Jr. Warrick E.
Schering Corporation
LandOfFree
Method for preventing injection site abscess does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing injection site abscess, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing injection site abscess will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-946877